180 related articles for article (PubMed ID: 18854559)
1. Evidence mounts for the efficacy of radioimmunotherapy for B-cell lymphomas.
Press OW
J Clin Oncol; 2008 Nov; 26(32):5147-50. PubMed ID: 18854559
[No Abstract] [Full Text] [Related]
2. Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma.
Cheson BD; Leonard JP
N Engl J Med; 2008 Aug; 359(6):613-26. PubMed ID: 18687642
[No Abstract] [Full Text] [Related]
3. Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
Morschhauser F; Radford J; Van Hoof A; Vitolo U; Soubeyran P; Tilly H; Huijgens PC; Kolstad A; d'Amore F; Gonzalez Diaz M; Petrini M; Sebban C; Zinzani PL; van Oers MH; van Putten W; Bischof-Delaloye A; Rohatiner A; Salles G; Kuhlmann J; Hagenbeek A
J Clin Oncol; 2008 Nov; 26(32):5156-64. PubMed ID: 18854568
[TBL] [Abstract][Full Text] [Related]
4. High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.
Devizzi L; Guidetti A; Tarella C; Magni M; Matteucci P; Seregni E; Chiesa C; Bombardieri E; Di Nicola M; Carlo-Stella C; Gianni AM
J Clin Oncol; 2008 Nov; 26(32):5175-82. PubMed ID: 18854569
[TBL] [Abstract][Full Text] [Related]
5. Radiobiology of radioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin's lymphoma.
Hernandez MC; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1274-87. PubMed ID: 15275710
[TBL] [Abstract][Full Text] [Related]
6. [Targeted destruction of lymphomas with the aid of radioimmunotherapy. Tumor antibodies isotope taxi].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373026
[No Abstract] [Full Text] [Related]
7. Radioimmunotherapy for B-cell non-Hodgkin lymphoma.
Nowakowski GS; Witzig TE
Clin Adv Hematol Oncol; 2006 Mar; 4(3):225-31. PubMed ID: 16728934
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy: a novel treatment modality for B-cell non-Hodgkin's lymphoma.
Juweid M; DeNardo GL; Graham M; Vose J
Cancer Biother Radiopharm; 2003 Oct; 18(5):673-4. PubMed ID: 14629816
[No Abstract] [Full Text] [Related]
9. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeled antibody therapy of B-cell lymphomas.
Press OW
Semin Oncol; 1999 Oct; 26(5 Suppl 14):58-65. PubMed ID: 10561019
[TBL] [Abstract][Full Text] [Related]
11. [Radioimmunotherapy with 90Y-ibritumomab tiuxetan in lymphomas].
Setoain X; López-Guillermo A; Ruiz A; Pons F
Rev Esp Med Nucl; 2006; 25(1):55-68; quiz 69-70.. PubMed ID: 16540015
[No Abstract] [Full Text] [Related]
12. The expanding role of rituximab and radioimmunotherapy in the treatment of B-cell lymphomas.
Jacobs SA; Foon KA
Expert Opin Biol Ther; 2007 Nov; 7(11):1749-62. PubMed ID: 17961097
[TBL] [Abstract][Full Text] [Related]
13. Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.
Subbiah K; Hamlin DK; Pagel JM; Wilbur DS; Meyer DL; Axworthy DB; Mallett RW; Theodore LJ; Stayton PS; Press OW
J Nucl Med; 2003 Mar; 44(3):437-45. PubMed ID: 12621012
[TBL] [Abstract][Full Text] [Related]
14. The radioisotope contributes significantly to the activity of radioimmunotherapy.
Davis TA; Kaminski MS; Leonard JP; Hsu FJ; Wilkinson M; Zelenetz A; Wahl RL; Kroll S; Coleman M; Goris M; Levy R; Knox SJ
Clin Cancer Res; 2004 Dec; 10(23):7792-8. PubMed ID: 15585610
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy for B-cell lymphoma: Y90 ibritumomab tiuxetan and I(131) tositumomab.
Davies AJ
Oncogene; 2007 May; 26(25):3614-28. PubMed ID: 17530015
[TBL] [Abstract][Full Text] [Related]
16. Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin's lymphoma and HIV infection.
Spina M; Sparano JA; Jaeger U; Rossi G; Tirelli U
AIDS; 2003 Jan; 17(1):137-8. PubMed ID: 12478085
[No Abstract] [Full Text] [Related]
17. Whither Radioimmunotherapy: To Be or Not To Be?
Green DJ; Press OW
Cancer Res; 2017 May; 77(9):2191-2196. PubMed ID: 28428282
[TBL] [Abstract][Full Text] [Related]
18. Some like it hot!
Cheson BD
J Clin Oncol; 2001 Oct; 19(19):3908-11. PubMed ID: 11579110
[No Abstract] [Full Text] [Related]
19. [Radioimmunotherapy for B-cell lymphoma].
Tobinai K
Rinsho Ketsueki; 2006 Jun; 47(6):463-70. PubMed ID: 16862974
[No Abstract] [Full Text] [Related]
20. High dose radioimmunotherapy in relapsed B-cell lymphoma with I-131 rituximab.
Becker W; Behr T
Ann Hematol; 2001; 80 Suppl 3():B130-1. PubMed ID: 11757696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
